2025 Guide: Age-Reversal Technology Investment Risks, Biotech Graduate School Alternatives & Clinical Lab Regulation Updates
2025’s trillion-dollar age-reversal tech sector carries hidden risks—70% of early investments fail preclinical trials (Biotech Investment Research 2024). Meanwhile, biotech